1. Thirtamara-Rajamani, Keerthi, Li, Peipei, Escobar Galvis, Martha L, Brundin, Patrik, Brundin, Lena. . Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson's Disease? In Journal of Parkinson's disease, 7, 577-587. doi:10.3233/JPD-171240. https://pubmed.ncbi.nlm.nih.gov/29103054/
2. Martí-Massó, Jose Felix, Bergareche, Alberto, Makarov, Vladimir, Buxbaum, Joseph D, Paisán-Ruiz, Coro. 2013. The ACMSD gene, involved in tryptophan metabolism, is mutated in a family with cortical myoclonus, epilepsy, and parkinsonism. In Journal of molecular medicine (Berlin, Germany), 91, 1399-406. doi:10.1007/s00109-013-1075-4. https://pubmed.ncbi.nlm.nih.gov/23955123/
3. Koshiguchi, Manami, Hirai, Shizuka, Egashira, Yukari. 2018. PGC1α regulates ACMSD expression through cooperation with HNF4α. In Amino acids, 50, 1769-1773. doi:10.1007/s00726-018-2652-1. https://pubmed.ncbi.nlm.nih.gov/30232574/
4. Egashira, Yukari, Sato, Makiko, Tanabe, Atsushi, Fujigaki, Suwako, Sanada, Hiroo. . Dietary linoleic acid suppresses gene expression of rat liver alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD) and increases quinolinic acid in serum. In Advances in experimental medicine and biology, 527, 671-4. doi:. https://pubmed.ncbi.nlm.nih.gov/15206789/
5. Egashira, Yukari, Murotani, Gen, Tanabe, Atsushi, Sato, Mayuki, Sanada, Hiroo. . Differential effects of dietary fatty acids on rat liver alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase activity and gene expression. In Biochimica et biophysica acta, 1686, 118-24. doi:. https://pubmed.ncbi.nlm.nih.gov/15522828/
6. Pellicciari, Roberto, Liscio, Paride, Giacchè, Nicola, Raffaelli, Nadia, Auwerx, Johan. 2018. α-Amino-β-carboxymuconate-ε-semialdehyde Decarboxylase (ACMSD) Inhibitors as Novel Modulators of De Novo Nicotinamide Adenine Dinucleotide (NAD+) Biosynthesis. In Journal of medicinal chemistry, 61, 745-759. doi:10.1021/acs.jmedchem.7b01254. https://pubmed.ncbi.nlm.nih.gov/29345930/
智鼠故事 
